Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Condition: Gastroesophageal Reflux Disease (GERD) Interventions: Drug: IW-3718; Drug: placebo Sponsor: Ironwood Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials